These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8025768)

  • 1. Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.
    O'Connor BJ; Uden S; Carty TJ; Eskra JD; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1994 Jul; 150(1):35-40. PubMed ID: 8025768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of platelet-activating factor induced bronchoconstriction by nedocromil sodium.
    Hayes JP; Chung KF; Barnes PJ
    Eur Respir J; 1992 Nov; 5(10):1193-6. PubMed ID: 1336735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219.
    Kidney JC; Ridge SM; Chung KF; Barnes PJ
    Am Rev Respir Dis; 1993 Jan; 147(1):215-7. PubMed ID: 8420421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled PAF stimulates leukotriene and thromboxane A2 production in humans.
    Taylor IK; Ward PS; Taylor GW; Dollery CT; Fuller RW
    J Appl Physiol (1985); 1991 Oct; 71(4):1396-402. PubMed ID: 1661723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor.
    Spring J; Johnston SR; Seale J; Ind PW
    Thorax; 1992 Nov; 47(11):948-51. PubMed ID: 1361250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen.
    Kuitert LM; Hui KP; Uthayarkumar S; Burke W; Newland AC; Uden S; Barnes NC
    Am Rev Respir Dis; 1993 Jan; 147(1):82-6. PubMed ID: 8420437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness.
    Wardlaw AJ; Chung KF; Moqbel R; MacDonald AJ; Hartnell A; McCusker M; Collins JV; Barnes PJ; Kay AB
    Am Rev Respir Dis; 1990 Feb; 141(2):386-92. PubMed ID: 2405759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma.
    Echazarreta AL; Gómez FP; Ribas J; Achaval M; Barberà JA; Roca J; Chung KF; Rodriguez-Roisin R
    Eur Respir J; 1999 Sep; 14(3):616-21. PubMed ID: 10543284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects.
    Kaye MG; Smith LJ
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):993-7. PubMed ID: 2183659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma.
    Gómez FP; Roca J; Barberà JA; Chung KF; Peinado VI; Rodriguez-Roisin R
    Eur Respir J; 1998 Apr; 11(4):835-9. PubMed ID: 9623685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.
    Roberts NM; McCusker M; Chung KF; Barnes PJ
    Br J Clin Pharmacol; 1988 Jul; 26(1):65-72. PubMed ID: 3203062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma.
    Gómez FP; Iglesia R; Roca J; Barberà JA; Chung KF; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1559-64. PubMed ID: 9603138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects.
    Bellofiore S; Ciancio N; Pennisi A; Coco G; Passanisi G; Ricciardolo FL; Novo S; Di Maria GU
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):288-92. PubMed ID: 8000412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation.
    Díaz O; Barberà JA; Marrades R; Chung KF; Roca J; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1997 Jul; 156(1):17-22. PubMed ID: 9230720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on PAF-induced airway responses in neonatally immunized rabbits.
    Herd CM; Donigi-Gale D; Shoupe TS; Page CP
    Br J Pharmacol; 1992 Dec; 107(4):1108-15. PubMed ID: 1467833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salbutamol inhibits pulmonary effects of platelet activating factor in man.
    Roca J; Félez MA; Chung KF; Barberà JA; Rotger M; Santos C; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1740-4. PubMed ID: 7767515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
    Sakamoto T; Elwood W; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No increase in plasma histamine during PAF-induced airway obstruction in allergic asthmatics.
    Louis R; Bury T; Corhay JL; Radermecker M
    Chest; 1993 Sep; 104(3):806-10. PubMed ID: 8365293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of thromboxane A2 in the development of airway responsiveness after platelet activating factor inhalation in dogs].
    Imai T; Adachi M; Idaira K; Hiyama T; Suganuma T; Takahashi T; Saito C; Maeda M; Tsuji A
    Arerugi; 1991 Jan; 40(1):37-45. PubMed ID: 2029218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo.
    Alabaster VA; Keir RF; Parry MJ; de Souza RN
    Agents Actions Suppl; 1991; 34():221-7. PubMed ID: 1793066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.